· Presentation
– Identification of Hypomorphic and Pathogenic ATM variants via High-throughput Functional Screening. Association For Molecular Pathology Annual Meeting & Expo, Boston, USA, 2025 [Talk]
– CRISPR-based approaches to elucidate the pathogenicity of human nucleotide variants. Korean Society of Genetic Diagnostics, Seoul, Republic of Korea, 2025 [Talk]
– Gene editing for functional evaluation of genetic variants associated with hereditary cancer syndrome. Yonsei Hereditary Cancer Symposium, Seoul, Republic of Korea, 2024 [Talk]
· Bibliography-Main authorship
– Lee KS*, Min JG*, Cheong Y, Oh HC, Jung SY, Park JI, Song M, Seo JH, Cho SR, Kim HH. Functional assessment of all ATM SNVs using prime editing and deep learning. Cell. 2025 Sep 4;188(18):5081-5099.e27. doi: 10.1016/j.cell.2025.05.046. Epub 2025 Jun 27.
– Lee KS*, Jang J, Jang H, Kang H, Rim JH, Lim JB. Better Prediction of Clinical Outcome with Estimated Glomerular Filtration Rate by CKD-EPI 2021. J Appl Lab Med. 2024 Oct 4:jfae103. doi: 10.1093/jalm/jfae103. Online ahead of print.
– Lee KS*, Lee CK, Kwon SS, Kwon WS, Park S, Lee ST, Choi JR, Rha SY, Shin S. Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer. Clin Chem Lab Med. 2023 Jul 13;62(1):178-186. doi: 10.1515/cclm-2023-0261. Print 2024 Jan 26.
